Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Investigating Treatment Response in Obsessive-Compulsive Disorder Through Neuromodulation and Patient-Derived Induced Pluripotent Stem Cell Models: Preliminary Clinical Observations from a Translational Study.

Brain sciences·2026

Same author

Pre-treatment circulating microRNA signatures predict outcomes of anti-CD19 CAR T-cell therapy.

Haematologica·2026

Same author

A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.

American journal of hematology·2026

Same author

Immune-related adverse events in the treatment of Hodgkin lymphoma with immune checkpoint inhibitors.

British journal of haematology·2026

Same author

MACOP-B in Adult Langerhans Cell Histiocytosis Confirms Durable Organ Responses at an Updated Long-Term Follow-Up.

American journal of hematology·2026

Same author

Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy.

Leukemia & lymphoma·2026

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

A dimerizable cationic lipid with potential for gene delivery.

Gabriele Candiani¹, Daniele Pezzoli, Mariasara Cabras

¹CNR, Istituto di Chimica del Riconoscimento Molecolare, Milan, Italy. gabriele.candiani@polimi.it

The Journal of Gene Medicine

|March 15, 2008

Summary

The cationic lipid SH-14 enhances gene transfer efficiency in cell cultures, even in the presence of serum. This novel reagent offers improved transfection rates with reduced cytotoxicity, paving the way for in vivo applications.

More Related Videos

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Related Experiment Videos

Last Updated: Jul 6, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Area of Science:

Biotechnology
Molecular Biology
Gene Therapy

Background:

Current gene transfer methods face low efficiency and cytotoxicity issues, especially in serum-containing media.
Developing a lipid formulation that maintains transfection efficiency in serum is crucial for in vivo applications.

Purpose of the Study:

To evaluate the cationic lipid SH-14 as a novel transfection reagent.
To assess SH-14's ability to form lipoplexes, its cytotoxicity, and transfection efficiency in the presence of serum.

Main Methods:

Investigated SH-14's dimerization with DNA, critical micelle concentration, and intrinsic toxicity.
Assessed in vitro cytotoxicity and transfection efficiency of SH-14/plasmid DNA lipoplexes.
Compared transfection efficiency and cytotoxicity in serum-free versus complete media.

Main Results:

Lipoplexes at charge ratio 10 (295 nm diameter, +20 mV surface charge) showed optimal balance between efficiency and tolerability.
SH-14 exhibited consistent cytotoxicity whether alone or complexed.
Transfection in complete medium over 48 hours increased efficiency by 73% and cell viability by 24%.
High serum concentrations (10-50%) with increased plasmid dose (>72% transfection) showed minimal cytotoxicity.

Conclusions:

SH-14 demonstrates significant potential as a novel transfection reagent.
SH-14 is effective for gene transfer in the presence of serum, overcoming a major limitation of current methods.